Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome - San Francisco Stem Cell Treatment Center

Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome

Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome

Sjögren syndrome (SS) is a systemic autoimmune disease characterized by dry mouth and eyes, and the cellular and molecular mechanisms for its pathogenesis are complex. Here we reveal, for the first time, that bone marrow mesenchymal stem cells in SS-like NOD/Ltj mice and human patients were defective in immunoregulatory functions.

Read More About Allogeneic Mesenchymal Stem Cell Treatment

San Francisco Stem Cell Treatment Center

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

Thank you for your interest in the San Francisco Stem Cell Treatment Center. You have been added to our list.